Antithrombotische Therapie bei akutem Koronarsyndrom

Schlüsselwörter

Antithrombotische Therapie - Akutes Koronarsyndrom - Antikoagulantien - Thrombozytenhemmer

Keywords

antithrombotic therapy - acute coronary syndrome - anticoagulants - antiplatelets

• Literatur

• 1 Achenbach S, Szardien S, Zeymer U et al. Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie des akuten Koronarsyndroms ohne persistierende ST-Streckenhebung. Kardiologe 2012; 6: 283-301
• 2 Hamm CW, Bassand JP, Agewall S. The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054
• 3 Lincoff AM, Bittl JA, Harrington RA et al. Bivalirudin an provisional glycoprotein IIb/IIIa blockade compared with heparin an planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003; 289: 853-863
• 4 Lip GY, Huber K et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting. Eur Heart J 2010; 31: 1311-1318
• 5 Mega JL, Braunwald E, Wiviott DE et al. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome. N Engl J Med 2012; 366: 9-19
• 6 Mehran R, Lansky AJ, Witzenbichler B et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009; 374: 1149-1159
• 7 Mehta SR, Tanguay JF, Jolly SS et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorail trial. Lancet 2010; 376: 1233-1243
• 8 Montalescot G, Bolognese L, Dudek D et al. Pretreatment with Prasugrel in Non-ST-Segment Elevation acute Coronary Syndromes. N Engl J Med 2013; 369: 999-1010
• 9 Steg PG, van’t Hof A et al. Bivalirudin Startes during Emergency Transport for Primary PCI. N Engl J Med 2013; 369: 2207-2217
• 10 Steg PG, James SK, Atar D et al. The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619
• 11 Stone GW, McLaruin BT, Cox DA et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216
• 12 The 5th Organization to Assess Strategies in Acute Ischemic Syndromes investigators. Comparison of Fondaparinux with Endoxaparin in acute coronary syndromes. N Engl J Med 2006; 354: 1464-1476
• 13 Wallentin L, Becker RC, Budaj A et al. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057
• 14 Wijns W, Kohl Ph, Danchin N et al. The Task Force on Myocardial Revacularization of the European Society of Cardiology (ESC) and the European Association for Cario-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-2555
• 15 Wiviott SD, Braunwald E, McCabe CH et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. TRITON-TIMI 38 Investigators. N Engl J Med 2007; 357: 2001-2015
• 16 Zeymer U. Therapie des akuten Herzinfarktes bei Patienten mit persistierender ST-Streckenhebung.. ESC Pocket Guidelines 2012